Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

JAK2-V617F Expression Results in a Cell-Intrinsic Expansion of Megakaryocyte Progenitors with Evidence of Myc Pathway Activation in Both Mature and Precursor Megakaryocytes By Single Cell RNA Sequencing

Joshua Siner, Jun Xia, Juo-Chin Yao, Kartik Singhal, Daniel Fisher, Lilian Antunes Heck, Malachi Griffith, Stephen Oh, Jorge Di Paola, Daniel C. Link

Blood (2024) 144 (Supplement 1): 6567.

https://doi.org/10.1182/blood-2024-211373

Published: 2024

Journal Articles

IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function

Sidan Li, Juo-Chin Yao, Karolyn A. Oetjen, Joseph R. Krambs, Jun Xia, Jingzhu Zhang, Amy P. Schmidt, Nichole M. Helton, Robert S. Fulton, Sharon E. Heath, Isaiah R. Turnbull, Gabriel Mbalaviele, Timothy J. Ley, Matthew J. Walter, Daniel C. Link

Blood (2022) 140 (14): 1607–1620.

https://doi.org/10.1182/blood.2022016084

Published: 2022

Includes: Supplemental data

Journal Articles

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Blood (2021) 138 (6): 452–463.

https://doi.org/10.1182/blood.2020010637

Published: 2021

Includes: Supplemental data

Journal Articles

Combined Inhibition of CXCR4 Signaling and System x c - Transporter Activity Induces Synthetic Lethality in T-ALL Cells By Suppressing Gsh and Inducing Ferroptosis

Jun Xia, PhD, Stephanie Sun, Matthew RM Jotte, Geoffrey L Uy, MD, Ella Sorani, PhD, Abi Vainstein, Liron Shemesh Davish, Katherine E Caldwell, William G Hawkins, Daniel C. Link, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-142735

Published: 2020

Journal Articles

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

Blood (2019) 134 (Supplement_1): 5592.

https://doi.org/10.1182/blood-2019-130040

Published: 2019

Journal Articles

CXCR4 Blockade By BL-8040 in T Cell Acute Lymphoblastic Leukemia Decreases Mitochondrial Mass and Induces Non-Apoptotic Cell Death

Jun Xia, PhD, Stephanie Sun, Matthew RM Jotte, Geoffrey L. Uy, MD, Osnat Bohana-Kashtan, PhD, Ella Sorani, PhD, Abi Vainstein, Amnon Peled, PhD, Daniel C. Link, MD

Blood (2019) 134 (Supplement_1): 2745.

https://doi.org/10.1182/blood-2019-128881

Published: 2019

Journal Articles

Ixazomib-Based Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma in Real-Life Practice Showed Comparable Efficacy and Safety Profile with Those Reported in Randomized Clinical Trials: A Multi-Center Study in China

Blood (2019) 134 (Supplement_1): 3181.

https://doi.org/10.1182/blood-2019-128614

Published: 2019

Journal Articles

The CXCR4 Antagonist, BL8040, Is Highly Active Against Human T-ALL in Preclinical Models

Jun Xia, PhD, Matthew RM Jotte, Stephanie Sun, Geoffrey L. Uy, MD, Abi Vainstein, Ella Sorani, PhD, Osnat Bohana-Kashtan, PhD, Stephen Shaw, PhD, Daniel C. Link, MD

Blood (2018) 132 (Supplement 1): 2700.

https://doi.org/10.1182/blood-2018-99-117213

Published: 2018

Journal Articles

Extended Genetic Testing in Severe Congenital Neutropenia May Identify Mutations That Inform Therapy

Daniel C. Link, MD, Vahagn Makaryan, MD, David H Spencer, MDPhD, Jun Xia, PhD, Audrey Anna Bolyard, RN, BS, David C Dale, MD

Blood (2018) 132 (Supplement 1): 2401.

https://doi.org/10.1182/blood-2018-99-116712

Published: 2018

Journal Articles

Somatic mutations and clonal hematopoiesis in congenital neutropenia

Blood (2018) 131 (4): 408–416.

https://doi.org/10.1182/blood-2017-08-801985

Published: 2018

Includes: Supplemental data

Journal Articles

Chemotherapy of GEP Regimen(Gemcitabine,etoposide and Pegaspargase) for the Patients with Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma: a Phase II Clinical Trial

Hua Wang, PhD, Xiao-qin Chen, Wei-da Wang, Zhong-jun Xia, MD

Blood (2017) 130 (Supplement 1): 2787.

https://doi.org/10.1182/blood.V130.Suppl_1.2787.2787

Published: 2017

Journal Articles

Mutation Burden in Hematopoietic Stem Cells Is Not Increased in Congenital Neutropenia

Jun Xia, Akiko Shimamura, MD PhD, Kasiani C. Myers, MD, Laurence A. Boxer, MD, David C. Dale, MD, Amrita Ramesh, Matthew Jotte, Daniel C. Link, MD

Blood (2016) 128 (22): 405.

https://doi.org/10.1182/blood.V128.22.405.405

Published: 2016

Journal Articles

G-CSF Augments Inotuzamab-Mediated Clearance of Acute Lymphoblastic Leukemia from the Bone Marrow

Jun Xia, Daniel C. Link, MD, Geoffrey L. Uy, MD

Blood (2014) 124 (21): 5502.

https://doi.org/10.1182/blood.V124.21.5502.5502

Published: 2014

Journal Articles

ER Stress-Induced Expression of CCAAT/Enhancer Binding Protein Gamma (C/EBPG) May Contribute to the Block in Granulocytic Differentiation in Severe Congenital Neutropenia

Jun Xia, Laurence A. Boxer, MD, Daniel C. Link, MD

Blood (2012) 120 (21): 8.

https://doi.org/10.1182/blood.V120.21.8.8

Published: 2012

Journal Articles

Ly6G ligation blocks recruitment of neutrophils via a β2-integrin–dependent mechanism

Jun-Xia Wang, Angela M. Bair, Sandra L. King, Ruslan Shnayder, Ya-Fang Huang, Chi-Chang Shieh, Roy J. Soberman, Robert C. Fuhlbrigge, Peter A. Nigrovic

Blood (2012) 120 (7): 1489–1498.

https://doi.org/10.1182/blood-2012-01-404046

Published: 2012

Includes: Supplemental data

Journal Articles

Conserved Transcriptional Deregulation Underlies GFI1 and ELANE Mutant Neutropenia

H. Andre Olsson, Ph.D, Andrew Plassard, Phillip Dexheimer, James D. Phelan, B.S., Ari Melnick, MD, Jun Xia, Daniel C. Link, MD, Joseph Opferman, Ph.D, Bruce J Aronow, PhD, H. Leighton Grimes, PhD

Blood (2011) 118 (21): 13.

https://doi.org/10.1182/blood.V118.21.13.13

Published: 2011

Journal Articles

Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane

Suparna Nanua, Mark Murakami, Jun Xia, David S. Grenda, Jill Woloszynek, Marie Strand, Daniel C. Link

Blood (2011) 117 (13): 3539–3547.

https://doi.org/10.1182/blood-2010-10-311704

Published: 2011

Includes: Supplemental data

Journal Articles

Loss of PERK Signaling Results in Impaired Granulopoiesis in Transgenic Mice Expressing Mutant Ela2 .

Suparna Nanua, MD, PhD, Jun Xia, PhD, Mark Murakami, MS, MD, Jill Woloszynek, Daniel C. Link, MD

Blood (2009) 114 (22): 551.

https://doi.org/10.1182/blood.V114.22.551.551

Published: 2009

Journal Articles

Assessment of Bone Marrow Mesenchymal Stem Cells Biological Characteristics in Patients with Polycythemia Vera

Xiaoyan Zhang, Jianyong Li, MD, PhD, Hua Lu, MD, PhD, Yujie Wu, Jun Xia, Limin Duan, Yaping Zhang

Blood (2008) 112 (11): 4585.

https://doi.org/10.1182/blood.V112.11.4585.4585

Published: 2008

Journal Articles

The Overall Analysis of JAK2 and MPL Mutation Status in Chinese MPD Patients by MassARRAY Assay

Sujiang Zhang, PhD, Jianyong Li, MD, PhD, Jingyi Shi, Jun Xia

Blood (2008) 112 (11): 5259.

https://doi.org/10.1182/blood.V112.11.5259.5259

Published: 2008

NARROW

JAK2-V617F Expression Results in a Cell-Intrinsic Expansion of Megakaryocyte Progenitors with Evidence of Myc Pathway Activation in Both Mature and Precursor Megakaryocytes By Single Cell RNA Sequencing

IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Combined Inhibition of CXCR4 Signaling and System x c - Transporter Activity Induces Synthetic Lethality in T-ALL Cells By Suppressing Gsh and Inducing Ferroptosis

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

CXCR4 Blockade By BL-8040 in T Cell Acute Lymphoblastic Leukemia Decreases Mitochondrial Mass and Induces Non-Apoptotic Cell Death

Ixazomib-Based Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma in Real-Life Practice Showed Comparable Efficacy and Safety Profile with Those Reported in Randomized Clinical Trials: A Multi-Center Study in China

The CXCR4 Antagonist, BL8040, Is Highly Active Against Human T-ALL in Preclinical Models

Extended Genetic Testing in Severe Congenital Neutropenia May Identify Mutations That Inform Therapy

Somatic mutations and clonal hematopoiesis in congenital neutropenia

Chemotherapy of GEP Regimen(Gemcitabine,etoposide and Pegaspargase) for the Patients with Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma: a Phase II Clinical Trial

Mutation Burden in Hematopoietic Stem Cells Is Not Increased in Congenital Neutropenia

G-CSF Augments Inotuzamab-Mediated Clearance of Acute Lymphoblastic Leukemia from the Bone Marrow

ER Stress-Induced Expression of CCAAT/Enhancer Binding Protein Gamma (C/EBPG) May Contribute to the Block in Granulocytic Differentiation in Severe Congenital Neutropenia

Ly6G ligation blocks recruitment of neutrophils via a β2-integrin–dependent mechanism

Conserved Transcriptional Deregulation Underlies GFI1 and ELANE Mutant Neutropenia

Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane

Loss of PERK Signaling Results in Impaired Granulopoiesis in Transgenic Mice Expressing Mutant Ela2 .

Assessment of Bone Marrow Mesenchymal Stem Cells Biological Characteristics in Patients with Polycythemia Vera

The Overall Analysis of JAK2 and MPL Mutation Status in Chinese MPD Patients by MassARRAY Assay

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only